Expression of Lipid Peroxidation Markers in the Tear Film and Ocular Surface of Patients with Non-Sjogren Syndrome: Potential Biomarkers for Dry Eye Disease

ABSTRACT Purpose: To investigate the expression of lipid peroxidation markers in the tear film and ocular surface and their correlation with disease severity in patients with dry eye disease. Methods: The concentrations of hexanoyl-lysine (HEL), 4-hydroxy-2-nonenal (HNE), and malondialdehyde (MDA) were measured with enzyme-linked immunosorbent assays in tears obtained from 44 patients with non-Sjogren syndrome dry eye and 33 control subjects. The correlations between the marker levels and the tear film and ocular surface parameters, including tear film break-up time (BUT), Schirmer tear value, tear clearance rate, keratoepitheliopathy scores, corneal sensitivity, conjunctival goblet cell density, and symptom score, were analyzed. The expression of the lipid peroxidation markers HEL, 4-HNE, and MDA in the conjunctiva was evaluated using immunohistochemistry. Results: The concentrations of HEL, 4-HNE, and MDA were 279.84 ± 69.98 nmol/L, 0.02 ± 0.01 μg/mL, and 3.80 ± 1.05 pmol/mg in control subjects and 283.21 ± 89.67 nmol/L (p = 0.97), 0.20 ± 0.03 μg/mL (p < 0.01), and 13.32 ± 4.03 pmol/mg (p < 0.01) in dry eye patients. 4-HNE and MDA levels significantly correlated with BUT, Schirmer tear value, tear clearance rate, keratoepitheliopathy scores, conjunctival goblet cell density, and symptom score (p < 0.05), whereas HEL levels did not correlate with these parameters. Staining intensities for 4-HNE and MDA increased in dry eye patients. Conclusions: The expression of late lipid peroxidation markers, 4-HNE and MDA, increases in the tear film and ocular surface of patients with dry eye. The levels correlate with various tear film and ocular surface parameters and may reflect the severity of dry eye disease.

[1]  K. Yoon,et al.  Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress. , 2007, Investigative ophthalmology & visual science.

[2]  T. Sundqvist,et al.  Intracellular oxidative activation in synovial fluid neutrophils from patients with rheumatoid arthritis but not from other arthritis patients. , 2007, The Journal of rheumatology.

[3]  S. Bonini,et al.  Molecular and cellular biomarkers in dry eye disease and ocular allergy , 2012, Current opinion in allergy and clinical immunology.

[4]  A. Spector,et al.  Oxidative stress‐induced cataract: mechanism of action , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  F. Guglielmi,et al.  Protection against ultraviolet B-induced oxidative DNA damage in rabbit corneal-derived cells (SIRC) by 4-coumaric acid. , 2003, Toxicology.

[6]  M. Viitanen,et al.  Effects of Oral Sea Buckthorn Oil on Tear Film Fatty Acids in Individuals With Dry Eye , 2011, Cornea.

[7]  K. Tsubota,et al.  Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. , 2007, Investigative ophthalmology & visual science.

[8]  H. Schipper,et al.  Oxidative stress in diseases of the human cornea. , 2008, Free radical biology & medicine.

[9]  H. Esterbauer,et al.  Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. , 1990, Methods in enzymology.

[10]  K. Yoon,et al.  Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. , 2010, Investigative ophthalmology & visual science.

[11]  K. Nair,et al.  Mitochondrial longevity pathways. , 2011, Biochimica et biophysica acta.

[12]  K. Yoon,et al.  Application of Umbilical Cord Serum Eyedrops for the Treatment of Dry Eye Syndrome , 2006, Cornea.

[13]  C. Schwartz,et al.  Resolvin E1 (RX-10001) Reduces Corneal Epithelial Barrier Disruption and Protects Against Goblet Cell Loss in a Murine Model of Dry Eye , 2012, Cornea.

[14]  K. Tsubota,et al.  Age-related dysfunction of the lacrimal gland and oxidative stress: evidence from the Cu,Zn-superoxide dismutase-1 (Sod1) knockout mice. , 2012, The American journal of pathology.

[15]  K. Tsubota,et al.  UV dose-dependent caspase activation in a corneal epithelial cell line , 2004, Current eye research.

[16]  K. Tsubota,et al.  Alterations of the tear film and ocular surface health in chronic smokers , 2008, Eye.

[17]  K. Tsubota,et al.  Tear cytokine and ocular surface alterations following brief passive cigarette smoke exposure. , 2008, Cytokine.

[18]  J. Alió,et al.  Effect of Topical Antioxidant Therapy on Experimental Infectious Keratitis , 1995, Cornea.

[19]  F. Breedveld,et al.  Linker for activation of T cells: sensing redox imbalance. , 2002, Methods in enzymology.

[20]  H. Ovadia,et al.  Anti-inflammatory effects of alpha linolenic acid on human corneal epithelial cells. , 2012, Investigative ophthalmology & visual science.

[21]  K. Tsubota,et al.  Corneal damage and lacrimal gland dysfunction in a smoking rat model. , 2011, Free radical biology & medicine.

[22]  T. Osawa,et al.  Detection of lipid-lysine amide-type adduct as a marker of PUFA oxidation and its applications. , 2010, Archives of biochemistry and biophysics.

[23]  Y. Shimomura,et al.  Preparation of a monoclonal antibody to N(epsilon)-(Hexanonyl)lysine: application to the evaluation of protective effects of flavonoid supplementation against exercise-induced oxidative stress in rat skeletal muscle. , 2000, Biochemical and biophysical research communications.

[24]  G. Ansari,et al.  Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. , 2010, Arthritis and rheumatism.

[25]  Zhengri Li,et al.  Blue light-induced oxidative stress in human corneal epithelial cells: protective effects of ethanol extracts of various medicinal plant mixtures. , 2014, Investigative ophthalmology & visual science.

[26]  Y. Shimomura,et al.  Preparation of a Monoclonal Antibody to Nϵ-(Hexanonyl)lysine: Application to the Evaluation of Protective Effects of Flavonoid Supplementation against Exercise-Induced Oxidative Stress in Rat Skeletal Muscle , 2000 .

[27]  Wenbo Wang,et al.  Relation between Gastric Cancer and Protein Oxidation, DNA Damage, and Lipid Peroxidation , 2013, Oxidative medicine and cellular longevity.

[28]  Christophe Baudouin,et al.  The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.

[29]  K. Tsubota,et al.  Evaluation of lipid oxidative stress status in Sjögren syndrome patients. , 2013, Investigative ophthalmology & visual science.

[30]  D. Gritz,et al.  Histochemical localization of superoxide production in experimental autoimmune uveitis. , 1991, Current eye research.

[31]  C. Joo,et al.  Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. , 2012, Investigative ophthalmology & visual science.

[32]  Han-Jin Oh,et al.  Expression of CCR5 and Its Ligands CCL3, -4, and -5 in the Tear Film and Ocular Surface of Patients with Dry Eye Disease , 2012, Current eye research.

[33]  K. Ward,et al.  Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells , 2011, Molecular vision.

[34]  K. Yoon,et al.  Usefulness of Double Vital Staining With 1% Fluorescein and 1% Lissamine Green in Patients With Dry Eye Syndrome , 2011, Cornea.

[35]  M. Kubota,et al.  Changes in Cerebrospinal Fluid Biomarkers in Human Herpesvirus-6-Associated Acute Encephalopathy/Febrile Seizures , 2014, Mediators of inflammation.

[36]  C. Creuzot-Garcher,et al.  A multicentre, double‐masked, randomized, controlled trial assessing the effect of oral supplementation of omega‐3 and omega‐6 fatty acids on a conjunctival inflammatory marker in dry eye patients , 2011, Acta ophthalmologica.

[37]  De-Quan Li,et al.  Epithelial-immune cell interaction in dry eye. , 2008, Cornea.

[38]  H. Hashemi,et al.  Short-term consumption of oral omega-3 and dry eye syndrome. , 2013, Ophthalmology.

[39]  K. Yoon,et al.  Long Term Follow-up Results of Topical 0.05% Cyclosporine A in Patient with Dry Eye , 2008 .

[40]  J D Gottsch,et al.  Oxidative damage and age-related macular degeneration. , 1999, Molecular vision.

[41]  D. Dickinson,et al.  Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. , 2008, Life sciences.

[42]  S. Pflugfelder,et al.  Effects of Sequential Artificial Tear and Cyclosporine Emulsion Therapy on Conjunctival Goblet Cell Density and Transforming Growth Factor-β2 Production , 2008, Cornea.

[43]  R. Perricone,et al.  Glutathione: a key player in autoimmunity. , 2009, Autoimmunity reviews.

[44]  K. Tsubota,et al.  The Role of Oxidative Stress and Inflammation in Dry Eye Disease , 2009 .

[45]  F. Breedveld,et al.  Displacement of Linker for Activation of T Cells from the Plasma Membrane Due to Redox Balance Alterations Results in Hyporesponsiveness of Synovial Fluid T Lymphocytes in Rheumatoid Arthritis , 2000, The Journal of Immunology.

[46]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.